Search
Showing 1 - 14 of 14 results
Improving Management and Treatment of Thyroid Cancer
UCSF’s Julie Ann Sosa, MD, co-led an international task force establishing new clinical guidelines for the management of differentiated thyroid cancer.Novel Therapy Aims to Make Type 1 Diabetes Patients Insulin Free
UCSF providing laboratory-produced islet cell therapy as part of clinical trial for Type 1 diabetes patients.Diabetes Medication May Increase Risk of Perioperative Ketoacidosis
UCSF study finds sodium-glucose cotransporter-2 inhibitors also lower risk of post-operative acute kidney injury.Scientists Discover How to Make Ordinary Fat Cells Burn Calories
Researchers at UC San Francisco have figured out how to turn ordinary white fat cells, which store calories, into beige fat cells that burn calories to maintain body temperature.Scientists Discover a New Hormone that Can Build Strong Bones
A newly discovered hormone that keeps the bones of breastfeeding women strong could also help bone fractures heal and treat osteoporosis in the broader population.Prostate Cancer Test Is Missing Early Disease in Transgender Women
Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment, reports a new study led by UC San Francisco.Algorithm Improves Blood Sugar Control in Hospitalized Patients
Controlling blood sugar in the hospital setting is challenging for a variety of reasons including inconsistent caloric intake, changes in kidney and liver function, surgery, infections, and limitations in labor-intensive glucose monitoring and insulin administration.New Research Linking Type 1 Diabetes to Genetic Mutations May Lead to Precision Medicine
UCSF researchers have discovered specific genetic mutations that can cause type 1 diabetes. This groundbreaking work could result in effective precision treatments for patients.UCSF Case Study: Same-Day Discharge After Pheochromocytoma Removal
San Francisco endocrine surgeon Sanziana Roman, MD, performed a posterior retroperitoneoscopic adrenalectomy (PRA) to remove a pheochromocytoma. This approach enabled the patient to be discharged home within hours of surgery and avoid prolonged hospitalization, thereby minimizing COVID-19 risk.Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis
Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control and mice with pulmonary fibrosis had decreased lung fibrosis and increased survival.Virtual Inpatient Diabetes Management Tools Minimize COVID-19 Risk for Staff and Improve Patient Outcomes
Automated virtual tools for inpatient diabetes management in use at UC San Francisco have helped the medical staff deliver safe and effective patient care while reducing their exposure to SARS-CoV-2.UCSF’s Julie Ann Sosa, MD, Named President-Elect of the American Thyroid Association
Julie Ann Sosa, MD, MA, FACS, endocrine surgeon and chair of the Department of Surgery at UC San Francisco, has been named president-elect of the American Thyroid Association (ATA). She was previously the ATA’s treasurer.UCSF MD Link: Web-Based Communication Portal for Physicians
Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.Now Scheduling Referrals Within 24 Hours
Quan-Yang Duh, MD, Chief, Section of Endocrine Surgery, UCSF, and Sanziana Roman, MD, Medical Director, Endocrine Neoplasia Clinic, UCSF, provide an update on safe endocrine surgical patient care at UCSF.